CoChat
Sign Up
Cited by 47

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

miR-144/451 represses the LKB1/AMPK/mTOR pathway to promote red cell precursor survival during recovery from acute anemia

Fang, Xiao, Shen, Feiyang, Lechauve, Christophe, Xu, Peng, Zhao, Guowei, Itkow, Jacobi, Wu, Fan, Hou, Yaying, Wu, Xiaohui, Yu, Lingling, Xiu, Huiqing, Wang, Mengli, Zhang, Ruiling, Wang, Fangfang, Zhang, Yanqing, Wang, Daxin, Weiss, Mitchell J., Yu, Duonan·2018·Haematologica
DOI 10.3324/haematol.2017.177394PMC PMC5830375
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3324/haematol.2017.177394

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Show all 5 references

Research works printed but not linked: 45

  1. [1]Hosokawa K Muranski P Feng X Identification of novel microRNA signatures linked to acquired aplastic anemia. Haematologica. 2015; 100(12): 1534– 1545. 26354756 PMC4666329
  2. [2]Mendell JT Olson EN MicroRNAs in stress signaling and human disease. Cell. 2012; 148(6): 1172– 1187. 22424228 PMC3308137
  3. [3]Hattangadi SM Wong P Zhang L Flygare J Lodish HF From stem cell to red cell: regulation of erythropoiesis at multiple levels by multiple proteins, RNAs, and chromatin modifications. Blood. 2011; 118(24): 6258– 6268. 21998215 PMC3236116
  4. [4]Huang X Gschweng E Van Handel B Cheng D Mikkola HK Witte ON Regulated expression of microRNAs-126/126* inhibits erythropoiesis from human embryonic stem cells. Blood. 2011; 117(7): 2157– 2165. 21163928 PMC3062325
  5. [5]Wang F Zhu Y Guo L A regulatory circuit comprising GATA1/2 switch and microRNA-27a/24 promotes erythropoiesis. Nucleic Acids Res. 2014; 42(1): 442– 457. 24049083 PMC3874166
  6. [6]Zhai PF Wang F Su R The regulatory roles of microRNA-146b-5p and its target platelet-derived growth factor receptor α (PDGFRA) in erythropoiesis and megakaryocytopoiesis. J Biol Chem. 2014; 289(33): 22600– 22613. 24982425 PMC4132768
  7. [7]Fu YF Du TT Dong M Mir-144 selectively regulates embryonic α-hemoglobin synthesis during primitive erythropoiesis. Blood. 2008; 113(6): 1340– 1349. 18941117
  8. [8]Pase L Layton JE Kloosterman WP Carradice D Waterhouse PM Lieschke GJ miR-451 regulates zebrafish erythroid maturation in vivo via its target gata2. Blood. 2009; 113(8): 1794– 1804. 18849488 PMC2647672
  9. [9]Zhan M Miller CP Papayannopoulou T Stamatoyannopoulos G Song CZ MicroRNA expression dynamics during murine and human erythroid differentiation. Exp Hematol. 2007; 35(7): 1015– 1025. 17588470 PMC1955220
  10. [10]Dore LC Amigo JD Dos Santos CO A GATA-1-regulated microRNA locus essential for erythropoiesis. Proc Natl Acad Sci USA. 2008; 105(9): 3333– 3338. 18303114 PMC2265118
  11. [11]Zhang L Flygare J Wong P Lim B Lodish HF miR-191 regulates mouse erythroblast enucleation by down-regulating Riok3 and Mxi1. Genes Dev. 2011; 25(2): 119– 124. 21196494 PMC3022257
  12. [12]Yang JS Maurin T Robine N Conserved vertebrate mir-451 provides a platform for Dicer-independent, Ago2-mediated microRNA biogenesis. Proc Natl Acad Sci USA. 2010; 107(34): 15163– 15168. 20699384 PMC2930549
  13. [13]Patrick DM Zhang CC Tao Y Defective erythroid differentiation in miR-451 mutant mice mediated by 14-3-3zeta. Genes Dev. 2010; 24(15): 1614– 1619. 20679397 PMC2912559
  14. [14]Rasmussen KD Simmini S Abreu-Goodger C The miR-144/451 locus is required for erythroid homeostasis. J Exp Med. 2010; 207(7): 1351– 1358. 20513743 PMC2901075
  15. [15]Yu D dos Santos CO Zhao G miR-451 protects against erythroid oxidant stress by repressing 14-3-3ζ. Genes Dev. 2010; 24(15): 1620– 1633. 20679398 PMC2912560
  16. [16]Yu D Carroll M Thomas-Tikhonenko A p53 status dictates responses of B lymphomas to monotherapy with proteasome inhibitors. Blood. 2007; 109(11): 4936– 4943. 17284530 PMC1885530
  17. [17]Gregory T Yu C Ma A Orkin SH Blobel GA Weiss MJ GATA-1 and erythropoietin cooperate to promote erythroid cell survival by regulating bcl-xL expression. Blood. 1999; 94(1): 87– 96. 10381501
  18. [18]Khandros E Thom CS D’Souza J Weiss MJ Integrated protein quality-control pathways regulate free α-globin in murine β-thalassemia. Blood. 2012; 119(22): 5265– 5275. 22427201 PMC3369615
  19. [19]Cheng Y Wu W Kumar SA Erythroid GATA1 function revealed by genome-wide analysis of transcription factor occupancy, histone modifications, and mRNA expression. Genome Res. 2009; 19(12): 2172– 2184. 19887574 PMC2792182
  20. [20]Palis J Segel GB Developmental biology of erythropoiesis. Blood Rev. 1998; 12(2): 106– 114. 9661799
  21. [21]Godlewski J Nowicki MO Bronisz A MicroRNA-451 regulates LKB1/AMPK signaling and allows adaptation to metabolic stress in glioma cells. Mol Cell. 2010; 37(5): 620– 632. 20227367 PMC3125113
  22. [23]Hawley SA Boudeau J Reid JL Complexes between the LKB1 tumor suppressor, STRAD α/β and MO25 α/β are upstream kinases in the AMP-activated protein kinase cascade. J Biol. 2003; 2(4): 28. 14511394 PMC333410
  23. [24]An X Schulz VP Li J Global transcriptome analyses of human and murine terminal erythroid differentiation. Blood. 2014; 123(22): 3466– 3477. 24637361 PMC4041167
  24. [25]Dasgupta B Chhipa RR Evolving lessons on the complex role of AMPK in normal physiology and cancer. Trends Pharmacol Sci. 2016; 37(3): 192– 206. 26711141 PMC4764394
  25. [26]Ginion A Auquier J Benton CR Inhibition of the mTOR/p70S6K pathway is not involved in the insulin-sensitizing effect of AMPK on cardiac glucose uptake. Am J Physiol Heart Circ Physiol. 2011; 301(2): H469– H477. 21602475
  26. [27]Laplante M Sabatini DM mTOR signaling in growth control and disease. Cell. 2012; 149(2): 274– 293. 22500797 PMC3331679
  27. [28]Kwon S Jeon JS Ahn C Sung JS Choi I Rapamycin regulates the proliferation of Huh7, a hepatocellular carcinoma cell line, by up-regulating p53 expression. Biochem Biophys Res Commun. 2016; 479(1): 74– 79. 27616194
  28. [29]Lee JY Nakada D Yilmaz OH mTOR activation induces tumor suppressors that inhibit leukemogenesis and deplete hematopoietic stem cells after Pten deletion. Cell Stem Cell. 2010; 7(5): 593– 605. 21040901 PMC2995996
  29. [30]Wang C Gao D Guo K Novel synergistic antitumor effects of rapamycin with bortezomib on hepatocellular carcinoma cells and orthotopic tumor model. BMC Cancer. 2012; 12: 166. 22559167 PMC3469344
  30. [31]Christophorou MA Martin-Zanca D Soucek L Temporal dissection of p53 function in vitro and in vivo. Nat Genet. 2005; 37(7): 718– 726. 15924142
  31. [32]Knight ZA Schmidt SF Birsoy K Tan K Friedman JM A critical role for mTORC1 in erythropoiesis and anemia. Elife. 2014; 3: e01913. 25201874 PMC4179304
  32. [34]Jones RG Plas DR Kubek S AMP-activated protein kinase induces a p53-dependent metabolic checkpoint. Mol Cell. 2005; 18(3): 283– 293. 15866171
  33. [35]Okoshi R Ozaki T Yamamoto H Activation of AMP-activated protein kinase induces p53-dependent apoptotic cell death in response to energetic stress. J Biol Chem. 2008; 283(7): 3979– 3987. 18056705
  34. [36]Tzatsos A Tsichlis PN Energy depletion inhibits phosphatidylinositol 3-kinase/Akt signaling and induces apoptosis via AMP-activated protein kinase-dependent phosphorylation of IRS-1 at Ser-794. J Biol Chem. 2007; 282(25): 18069– 18082. 17459875
  35. [37]Chakraborty A Uechi T Kenmochi N Guarding the ‘translation apparatus’: defective ribosome biogenesis and the p53 signaling pathway. Wiley Interdiscip Rev RNA. 2011; 2(4): 507– 522. 21957040
  36. [40]Augustine JJ Knauss TC Schulak JA Bodziak KA Siegel C Hricik DE Comparative effects of sirolimus and mycophenolate mofetil on erythropoiesis in kidney transplant patients. Am J Transplant. 2004; 4(12): 2001– 2006. 15575902
  37. [41]Ekberg H Bernasconi C Nöldeke J Cyclosporine, tacrolimus and sirolimus retain their distinct toxicity profiles despite low doses in the Symphony study. Nephrol Dial Transplant. 2010; 25(6): 2004– 2010. 20106825
  38. [42]Shameem R Hamid MS Wu S Risk of anemia attributable to everolimus in patients with cancer: a meta-analysis of randomized controlled trials. Anticancer Res. 2015; 35(4): 2333– 2340. 25862897
  39. [43]Diekmann F Rovira J Diaz-Ricart M mTOR inhibition and erythropoiesis: microcytosis or anaemia? Nephrol Dial Transplant. 2012; 27(2): 537– 541. 21785038
  40. [44]Socolovsky M Molecular insights into stress erythropoiesis. Curr Opin Hematol. 2007; 14(3): 215– 224. 17414210
  41. [45]Sankaran VG Weiss MJ Anemia: progress in molecular mechanisms and therapies. Nat Med. 2015; 21(3): 221– 230. 25742458 PMC4452951
  42. [46]Zhang X Camprecios G Rimmele P FOXO3-mTOR metabolic cooperation in the regulation of erythroid cell maturation and homeostasis. Am J Hematol. 2014; 89(10): 954– 963. 24966026 PMC4201594
  43. [47]Green RJ Herget M Outcomes of systemic/strategic team consultation: I. Overview and one-month results. Fam Process. 1989; 28(1): 37– 58. 2703051
  44. [48]Kloosterman WP Wienholds E de Bruijn E Kauppinen S Plasterk RH In situ detection of miRNAs in animal embryos using LNA-modified oligonucleotide probes. Nat Methods. 2006; 3(1): 27– 29. 16369549
  45. [50]Kim M Tan YS Cheng WC Kingsbury TJ Heimfeld S Civin CI MIR144 and MIR451 regulate human erythropoiesis via RAB14. Br J Haematol. 2015; 168(4): 583– 597. 25312678 PMC4314389

Cited by

Sorted by citations

See all 47

Metadata

Authors
Fang, X., Shen, F., Lechauve, C., Xu, P., Zhao, G., Itkow, J., Wu, F., Hou, Y., Wu, X., Yu, L., Xiu, H., Wang, M., Zhang, R., Wang, F., Zhang, Y., Wang, D., Weiss, M. J., & Yu, D.
Venue
Haematologica
Publisher
Ferrata Storti Foundation (Haematologica)
Published
2017-12-21
Volume
103
Issue
3
Pages
406-416
ISSN
  • 0390-6078
  • 1592-8721
DOI
10.3324/haematol.2017.177394
PMC
PMC5830375
Cited by
47
References
5
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review